Patent · US Active

Mutant RB69 DNA polymerase

US10336991B2 · kind B2 · utility

9Cited by
16References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2017
Grant dateJul 2, 2019
Priority date
Expiry dateFeb 1, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are mutant DNA-dependent polymerases which are derived from, or otherwise related to, wild type RB69 DNA polymerase. These mutant polymerases are capable of selectively binding labeled nucleotides. These mutant polymerases are also capable of incorporating a variety of naturally occurring and modified nucleotides, including, for example, terminator nucleotides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.